ZS launches mid-cap pharma vertical to help companies accelerate growth and maximize portfolio value
The new vertical brings together ZS expertise across R&D, commercialization, technology and analytics to address the distinct needs of mid-cap pharmaceutical companies.
EVANSTON, Ill. – October 20, 2026 – ZS, a global management consulting and technology firm, today announced the launch of its mid-cap pharma industry vertical, a dedicated area of focus designed to help mid-cap pharma companies scale with confidence and build the capabilities needed for their next phase of expansion. Building on ZS’s existing work in this space, the vertical will connect clients with specialized ZS expertise across commercial strategy, R&D, technology, advanced analytics and ZAIDYN® to help them navigate the challenges that come with rapid growth and increasing business demands.
“Mid-cap pharma companies are among the most dynamic organizations shaping the future of healthcare innovation, and they benefit from fit-for-purpose solutions and services,” said Nitin Jain, principal and leader of ZS’s mid-cap pharma vertical. “This dedicated focus allows us to bring more practical expertise, relevant insights and specialized talent to the segment as it continues to grow and evolve.”
“Mid-cap pharma companies occupy a distinct position within the industry. As they grow, many are balancing the agility that fueled their success with the need to build more mature commercial, operational and technology capabilities,” said Sandra Forero, ZS COO. “Sitting between emerging biopharma and the industry’s largest organizations, mid-cap pharma companies face a unique set of opportunities and challenges. Their evolving portfolios, organizational structures and growth ambitions require tailored solutions and services aligned to their complexity, operating model and pace of growth.”
The mid-cap pharma vertical reflects ZS’s expanding investment in serving the evolving needs of the pharmaceutical industry. By bringing together expertise from across the firm, ZS is strengthening its ability to support mid-cap pharma companies at a critical stage of growth and transformation.
About ZS
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000 employees in over 40 offices worldwide. To learn more, visit ZS or follow ZS on LinkedIn.